| DNTHDianthus Therapeutics, Inc. /DE/ | 4,208,368 | $361.3M |
| ORKAOruka Therapeutics, Inc. | 1,520,848 | $89.3M |
| CGONCG Oncology, Inc. | 1,288,948 | $87.2M |
| JBIOJade Biosciences, Inc. | 2,801,416 | $53.9M |
| CATXPerspective Therapeutics, Inc. | 12,099,998 | $48.8M |
| ELVNEnliven Therapeutics, Inc. | 800,000 | $32.2M |
| CNTXContext Therapeutics Inc. | 9,996,534 | $24.9M |
| TEVATeva Pharmaceutical Industries Limited | 650,100 | $20.6M |
| RGENREPLIGEN CORP | 155,600 | $18.4M |
| PVLAPALVELLA THERAPEUTICS, INC. | 140,000 | $17.7M |
| AKTSAktis Oncology Inc. | 937,132 | $17.2M |
| VIRVir Biotechnology, Inc. | 1,569,300 | $14.8M |
| KPTIKaryopharm Therapeutics Inc. | 927,482 | $6.4M |
| PHATPhathom Pharmaceuticals, Inc. | 498,780 | $5.6M |
| GILDGILEAD SCIENCES, INC. | 40,000 | $5.4M |
| MSLESatellos Bioscience Inc. | 775,538 | $5.3M |
| SCYXSCYNEXIS INC | 4,163,320 | $3.8M |
| ICLRICON plc | 32,000 | $3.7M |
| GPCRStructure Therapeutics Inc. | 78,000 | $3.4M |
| CRVSCorvus Pharmaceuticals, Inc. | 230,000 | $3.4M |
| GMABGenmab A/S | 100,000 | $2.7M |
| CORTCORCEPT THERAPEUTICS INC | 60,000 | $2.6M |
| NTLAIntellia Therapeutics, Inc. | 150,000 | $2.0M |
| MLTXMoonLake Immunotherapeutics | 100,000 | $1.8M |
| CRLCHARLES RIVER LABORATORIES INTERNATIONAL, INC. | 10,000 | $1.7M |
| RVMDREVOLUTION MEDICINES, INC. | 15,000 | $1.5M |
| ABVXAbivax SA | 10,000 | $1.1M |
| ABUSArbutus Biopharma Corp | 250,000 | $1.1M |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 3,800 | $1.0M |
| ABTABBOTT LABORATORIES | 10,000 | $908K |
| BBOTBridgeBio Oncology Therapeutics, Inc. | 87,706 | $761K |
| BBIOBridgeBio Pharma, Inc. | 10,000 | $711K |
| ACADACADIA PHARMACEUTICALS INC | 25,934 | $580K |
| LEGNLegend Biotech Corp | 15,000 | $353K |
| SVRASavara Inc | 50,000 | $262K |
| TRVITrevi Therapeutics, Inc. | 13,320 | $171K |